These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 21732213)

  • 1. The behavioral economics and neuroeconomics of reinforcer pathologies: implications for etiology and treatment of addiction.
    Bickel WK; Jarmolowicz DP; Mueller ET; Gatchalian KM
    Curr Psychiatry Rep; 2011 Oct; 13(5):406-15. PubMed ID: 21732213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The behavioral economics of substance use disorders: reinforcement pathologies and their repair.
    Bickel WK; Johnson MW; Koffarnus MN; MacKillop J; Murphy JG
    Annu Rev Clin Psychol; 2014; 10():641-77. PubMed ID: 24679180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excessive discounting of delayed reinforcers as a trans-disease process contributing to addiction and other disease-related vulnerabilities: emerging evidence.
    Bickel WK; Jarmolowicz DP; Mueller ET; Koffarnus MN; Gatchalian KM
    Pharmacol Ther; 2012 Jun; 134(3):287-97. PubMed ID: 22387232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward a behavioral economic understanding of drug dependence: delay discounting processes.
    Bickel WK; Marsch LA
    Addiction; 2001 Jan; 96(1):73-86. PubMed ID: 11177521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reinforcer Pathology: Implications for Substance Abuse Intervention.
    Bickel WK; Athamneh LN; Snider SE; Craft WH; DeHart WB; Kaplan BA; Basso JC
    Curr Top Behav Neurosci; 2020; 47():139-162. PubMed ID: 32462615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and neuroeconomics of drug addiction: competing neural systems and temporal discounting processes.
    Bickel WK; Miller ML; Yi R; Kowal BP; Lindquist DM; Pitcock JA
    Drug Alcohol Depend; 2007 Sep; 90 Suppl 1(Suppl 1):S85-91. PubMed ID: 17101239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The behavioral economics of will in recovery from addiction.
    Monterosso J; Ainslie G
    Drug Alcohol Depend; 2007 Sep; 90 Suppl 1(Suppl 1):S100-11. PubMed ID: 17034958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery from addiction: Behavioral economics and value-based decision making.
    Field M; Heather N; Murphy JG; Stafford T; Tucker JA; Witkiewitz K
    Psychol Addict Behav; 2020 Feb; 34(1):182-193. PubMed ID: 31599604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Reinforcer Pathology perspective on relapse.
    Bickel WK; Athamneh LN
    J Exp Anal Behav; 2020 Jan; 113(1):48-56. PubMed ID: 31789442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New dimensions in human laboratory models of addiction.
    Koob GF
    Addict Biol; 2009 Jan; 14(1):1-8. PubMed ID: 19133879
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel Therapeutics for Addiction: Behavioral and Neuroeconomic Approaches.
    Bickel WK; Mellis AM; Snider SE; Moody L; Stein JS; Quisenberry AJ
    Curr Treat Options Psychiatry; 2016 Sep; 3(3):277-292. PubMed ID: 28018836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economics as a factor in models of behavioral motivation and change.
    Montoya ID; Atkinson JS; Trevino RA
    Subst Use Misuse; 2000 Feb; 35(3):329-46. PubMed ID: 10714450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consumption and response output as a function of unit price: manipulation of cost and benefit components.
    Delmendo X; Borrero JC; Beauchamp KL; Francisco MT
    J Appl Behav Anal; 2009; 42(3):609-25. PubMed ID: 20190922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral economics of drug self-administration: an introduction.
    Hursh SR
    Drug Alcohol Depend; 1993 Sep; 33(2):165-72. PubMed ID: 8261881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral economic demand as a unifying language for addiction science: Promoting collaboration and integration of animal and human models.
    Strickland JC; Lacy RT
    Exp Clin Psychopharmacol; 2020 Aug; 28(4):404-416. PubMed ID: 32105136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excessive discounting of delayed reinforcers as a trans-disease process: Update on the state of the science.
    Bickel WK; Athamneh LN; Basso JC; Mellis AM; DeHart WB; Craft WH; Pope D
    Curr Opin Psychol; 2019 Dec; 30():59-64. PubMed ID: 30852411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Behavioral Economics and Neuroeconomics of Alcohol Use Disorders.
    MacKillop J
    Alcohol Clin Exp Res; 2016 Apr; 40(4):672-85. PubMed ID: 26993151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value, drug addiction and the brain.
    Loganathan K; Ho ETW
    Addict Behav; 2021 May; 116():106816. PubMed ID: 33453587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Problematic mobile phone use as impulsive choice: Development and empirical verification of a reinforcer-pathology model.
    Hayashi Y
    J Exp Anal Behav; 2024 Mar; 121(2):189-200. PubMed ID: 38148676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of constant versus varied reinforcers on preference and resistance to change.
    Milo JS; Mace FC; Nevin JA
    J Exp Anal Behav; 2010 May; 93(3):385-94. PubMed ID: 21119852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.